The occurrence of low-grade chronic inflammation in individuals with T2DM triggered an excessive secretion of inflammatory markers, including CRP, interleukin-6 (IL-6), TNF-α and monocyte chemokine 1(MCP-1). This evidence concerns the gene CCL2 and inflammatory response.